Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment

Update Il y a 4 ans
Reference: U1111-1176-9230

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare the effect of once-daily dosing of 14 mg oral semaglutide versus placebo, both in combination with metformin and/or sulfonylurea, basal insulin alone or metformin in combination with basal insulin on glycaemic control in subjects with type 2 diabetes mellitus and moderate renal impairment


Inclusion criteria

  • Diabetes Mellitus, Type 2

Links